stock
None
NASDAQ:PCRX
57.07
-1.56 (-2.66%)
As of 2022-06-30, 03:10 PM (EST)
52 Week Rng -
Market Cap -
Avg Volume -
1M Volatility -
Short Ratio -
P/E Ratio (TTM) -
P/E Ratio (Fwd) -
P/B Ratio -
Div & Yield -
SELL
250
×
ACTION
TICKER
SHARES
STATUS
BUY
100
Filled
ACTION
TICKER
SHARES
STATUS
BUY
316
Filled
ACTION
TICKER
SHARES
STATUS

IRAM2022Team4 IRAM 2022 Feb 2022

PCRX has already established itself as a leader in non-opioid pain management industry in the USA and they plan to become a global brand once they begin commercialization in Europe, Canada and China. With this we are looking at a 30% total market growth upon successful commercialization in these countries. The company is looking to penetrate the pediatrics market where 20% of orthopedic surgeries are pediatric patients, this will give them roughly $20M added revenue starting in 2022.

SELL
21
Filled
ACTION
TICKER
SHARES
STATUS

alonsona Stockfuse Continuum (US) Dec 2021

Automatic trade executed by Stockfuse to ensure margin compliance.

[SELL]
1,000
Filled
ACTION
TICKER
SHARES
STATUS
BUY
250
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
200
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
343
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
60
Filled
ACTION
TICKER
SHARES
STATUS
BUY
50
×
ACTION
TICKER
SHARES
STATUS
SELL
20
Filled
ACTION
TICKER
SHARES
STATUS
BUY
500
Filled
ACTION
TICKER
SHARES
STATUS
BUY
220
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
100
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
1
Filled
ACTION
TICKER
SHARES
STATUS
BUY
200
Filled
ACTION
TICKER
SHARES
STATUS
[BUY]
1
Filled
ACTION
TICKER
SHARES
STATUS
SELL
1,000
×
ACTION
TICKER
SHARES
STATUS
[SELL]
10,000
Filled
ACTION
TICKER
SHARES
STATUS
[BUY]
100
Filled
ACTION
TICKER
SHARES
STATUS
more
AAPL AMD AMZN FB PFE DO PKX TRGP TKC ACRX
Market data provided by Xignite, BATS BZX Real-Time Price, and SIX Financial Information.